Ethical issues in psychopharmacology

California State University, Northridge, Department of Philosophy, 18111 Nordhoff Street, Northridge, California 91330-8253, USA.
Journal of Medical Ethics (Impact Factor: 1.51). 08/2006; 32(7):405-10. DOI: 10.1136/jme.2005.013185
Source: PubMed


The marketing of selective serotonin reuptake inhibitors in the psychopharmacological industry presents a serious moral problem for the corporate model of medicine. In this paper I examine ethical issues relating to the efficacy and safety of these drugs. Pharmaceutical companies have a moral obligation to disclose all information in their possession bearing on the true risks and benefits of their drugs. Only then can patients make fully informed decisions about their treatment.

Full-text preview

Available from:
  • Source
    • "Second, setting, participants, demographic data, co-medication e.g. can limit the generalizability of the trial results [4], [5]. There is also increasing evidence of selective reporting in clinical trial findings, with some recent examples in pharmacologic treatment for depression and other psychiatric disorders [6], [7], [8], [9]. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Reporting guidelines (e.g. CONSORT) have been developed as tools to improve quality and reduce bias in reporting research findings. Trial registration has been recommended for countering selective publication. The International Committee of Medical Journal Editors (ICMJE) encourages the implementation of reporting guidelines and trial registration as uniform requirements (URM). For the last two decades, however, biased reporting and insufficient registration of clinical trials has been identified in several literature reviews and other investigations. No study has so far investigated the extent to which author instructions in psychiatry journals encourage following reporting guidelines and trial registration.
    Full-text · Article · Oct 2013 · PLoS ONE
  • Source

    Preview · Article · Jan 2007
  • [Show abstract] [Hide abstract]
    ABSTRACT: World health is at a critical crossroads. Diseases such as malaria, tuberculosis, and HIV/AIDS ravage many parts of the globe and new diseases such as SARS, West Nile virus, and avian flu threaten to spread quickly and virulently. A new global health movement is rapidly emerging to bring medical solutions to these immense world health problems. Desirable as this goal may be there are multiple negative consequences and side effects associated with this new movement. Using a biocultural approach, this article considers the wider social and cultural complications of the global health movement and questions whether the movement can really offer an untainted Rx for the world's ills.
    No preview · Article · Jun 2007 · New Literary History
Show more